Last reviewed · How we verify
NCT04788667
Effectiveness of a Health Education Programme for Prevention of Chronic Migraine: A Randomized Clinical Trial
NA trial testing A health education programme using a telerehabilitation platform in Chronic Migraine in 48 participants. Completed in 26 July 2024.
22 April 2024
Quick facts
| Lead sponsor | Universidad de Zaragoza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 19 April 2021 |
| Primary completion | 22 April 2024 |
| Estimated completion | 26 July 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- A health education programme using a telerehabilitation platform
Conditions studied
- Chronic Migraine — all drugs for Chronic Migraine →
Sponsor
Universidad de Zaragoza — full company profile →
Who can join
Adults 18 to 65, any sex, with Chronic Migraine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic migraine (CM) is a common and frequent disorder, which has a major impact on the quality of life of migraine sufferers, interfering with physical function, productivity at work, personal life and leisure, lifestyle and psychological well-being. The use of a prophylactic drug treatment is recommended if headache is present more than 8 days per month. In addition, several studies have shown benefits of non-pharmacological interventions such as self-management strategies, manual therapy and exercise. However, no studies have been found that analyse the beneficial effect of a combination of a preventive drug treatment and a health education programme. Thus, this project would offer a service of health education through a telerehabilitation programme for patients with chronic migraine under prophylactic drug treatment. The aim of this study is to compare the combination of a prophylactic drug therapy and a health education programme in the preventive treatment of patients with chronic migraine.based on the hypothesis that a health education program for chronic migraine patients could decrease the number of migraine days.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Supportive Self-Management Program for People With Chronic Headaches and Migraine: A Randomized Controlled Trial and Economic Evaluation.
Underwood M, Achana F, Carnes D, Eldridge S, et al · · 2023 · cited 16× · PMID 36526428 · DOI 10.1212/wnl.0000000000201518 -
Effectiveness of a Complementary Telehealth Education Program as a Preventive Treatment for Chronic Migraine: A Randomized Pilot Study.
Cordova-Alegre P, Herrero P, Santos-Lasaosa S, Navarro-Perez MP, et al · · 2024 · cited 2× · PMID 39597969 · DOI 10.3390/jcm13226825 -
Has the COVID-19 pandemic changed characteristics, administration modalities, and implementation of psychological interventions for chronic headache? An updated systematic review.
De Lucia A, Donisi V, Rimondini M, Del Piccolo L, et al · · 2026 · PMID 41923926 · DOI 10.1080/21642850.2026.2650006
Verify or expand the search:
- PubMed search for NCT04788667
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Migraine
Currently open trials in the same condition.
- NCT06974617 — Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine · NA · recruiting
- NCT06684249 — Efficacy of Nerve Block Versus Botox in Chronic Migraine Management · NA · recruiting
- NCT05337033 — Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial · Phase 2 · recruiting
- NCT06625060 — A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults · Phase 2 · recruiting
- NCT06450444 — The RECLAIM Study. · NA · recruiting
Other Universidad de Zaragoza trials
Trials by the same sponsor.
- NCT07497217 — Change in ATOR Screening Test Scores Over 12 Weeks · NA · recruiting
- NCT07395830 — Effects of a Multisensory VR Experience on Stress and User Experience · NA · not yet recruiting
- NCT07398040 — Clinical Impact of an Anti-Inflammatory Diet in Anxiety and Depression With AI · NA · enrolling by invitation
- NCT07066696 — Mindfulness and Compassion Program for the Improvement of Emotional and Behavioral Problems, Academic Performance and Sc · NA · not yet recruiting
- NCT07086209 — Optimizing Hamstring Rehabilitation With Amino Acids · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04788667 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Zaragoza
- Last refreshed: 29 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04788667.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing